Blogs

Isansys wins two SBRI Healthcare development contracts to improve patient safety and reduce risks for cancer patients

Abingdon, Oxfordshire, UK, 14th April 2014 – Isansys Lifecare Limited, the provider of complete real-time physiological patient status services and systems, today announces that it has won two SBRI (Small Business Research Initiative) Healthcare contracts. Granted as part of NHS England’s initiative to enhance the adoption of innovative devices and new technologies, the contracts have been signed with Papworth NHS Trust (Cambridge, UK) for Isansys to expand the functionality and applications of its CE-marked Patient Status Engine (PSE) in two theme areas– patient safety and cancer. Isansys is currently working with a number of hospitals and healthcare service providers to deliver patient monitoring services and patient status solutions based on the PSE platform.

Global regulatory affairs specialist ELC Group appoints Senior Regulatory Expert

Cambridge, UK, 3rd April 2014 – ELC Group, one of the fastest-growing providers of regulatory affairs, today announces the appointment of Jin-Hee Kang as Senior Regulatory Expert specialising in Biosimilars. Jin-Hee Kang will be leading on support for Biosimilars development, focusing on legislative changes surrounding market launch.

A former Associate Senior Director for Central Research Institute RA/CO with Celltrion Pharmaceuticals, Inc., Jin-Hee Kang was previously one of the key leaders behind the first monoclonal antibody biosimilar registration within the EMEA region, supervising the marketing authorisation from the feasibility studies to full launch logistics in over 130 countries.

She previously worked with Otsuka Pharmaceutical, Inc. as RA Manager for six years. Her facilitation of new drug approval and launch accomplished a 150 per cent growth in the Asia and Arab markets in just two years.

Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ – the industry’s first benchtop, HEPA-filtered hyp

Abingdon, UK, 12th November 2013. – Oxford Optronix, the leading provider of advanced
research instrumentation for the clinical medicine and life science industries, today announces the
formal launch of HypoxyLab™ – the industry’s first benchtop, HEPA-filtered,
precision-controlled hypoxia workstation. HypoxyLab creates optimal, contamination-free conditions
for a wide variety of cell-based research fields, including cancer biology, radiation cell biology,
cardiovascular research, apoptosis, neurology, stem cell research, multidisciplinary drug
development and proteomics.

HypoxyLab is a unique, fully-featured and easy-to-use hypoxia workstation that accurately reproduces
physiological conditions for cell-based research. HypoxyLab provides a highly stable, localised
environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely
controlled within a HEPA-filtered isolation work chamber.

Advanced research instrumentation pioneer Oxford Optronix to exhibit at Neuroscience 2013

Abingdon, UK, 29th October 2013. – Oxford Optronix, the leading provider of advanced
research instrumentation for the clinical medicine and life science industries will demonstrate its
latest innovative products for research professionals at Neuroscience 2013, the 43rd annual meeting
of the Society for Neuroscience in San Diego, California (9th – 13th November 2013). Oxford
Optronix will be exhibiting and available for meetings at Booth #1021.
The Neuroscience annual meeting is attended by scientists from around the world and includes major
featured and special lectures by leading scientists, more than 16,000 abstracts sharing new
findings, over 50 symposia and mini-symposia with comprehensive coverage of vital neuroscience
research topics, plus more than 600 exhibitors showcasing new tools, technologies, and publishing
opportunities. Neuroscience 2013 focusses on brain function, health, and disease, covering topics

Details announced for the World Research and Innovation Congress 2014

Bristol, UK - October 10th, 2013. Research Media, who produce the International Innovation series of publications, has announced details for next year’s World Research and Innovation Congress – Pioneers in Healthcare (WRIC) taking place on 4th and 5th June in Brussels. Themed ‘How we do research – maximising impact through collaboration’, the event will address key issues such as international collaboration, funding for research and supporting research excellence.
The future of healthcare research relies on innovation and collaboration. The event will attract a worldwide audience of scientific healthcare representatives who will benefit from a dynamic programme comprising presentations, workshops and interactive panel sessions.
The event will provide delegates with the opportunity to discuss the latest issues and developments in healthcare, hear about funding opportunities, share knowledge, network and form partnerships.

ISPM joins Digital Health Initiative at TM Forum’s Digital Disruption 2013, October 28th – 31st, San Jose McEnery Convention Cen

Sao Paulo, Brazil, October 10th, 2013. ISPM, a leading vendor of flexible service assurance and management software for telecommunications and IT infrastructure announces that it is participating in TM Forum’s Digital Health Initiative through the “eHealth - Curing the Complexity” Catalyst project which will be demonstrated at Digital Disruption 2013, Oct. 28th-31st, in San Jose, Calif.
For more information read the full news release here:
http://www.neondrum.com/public/public_release.php?id=1609

Pages

Subscribe to RSS - blogs